HEADER OXIDOREDUCTASE 20-OCT-14 4V3Z TITLE STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN COMPLEX TITLE 2 WITH 2-(2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)-N-(2-(3- FLUOROPHENYL) TITLE 3 CYCLOPROPYLMETHYL)ETHAN-1-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, BRAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, UNP RESIDUES 297-718; COMPND 5 SYNONYM: BNOS, CONSTITUTIVE NOS, NC-NOS, NOS TYPE I, NEURONAL NOS, N- COMPND 6 NOS, NNOS, PEPTIDYL-CYSTEINE S-NITROSYLASE NOS1, NEURONAL NITRIC COMPND 7 OXIDE SYNTHASE; COMPND 8 EC: 1.14.13.39; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,T.L.POULOS REVDAT 3 08-MAY-24 4V3Z 1 REMARK LINK REVDAT 2 04-MAR-15 4V3Z 1 JRNL REVDAT 1 24-DEC-14 4V3Z 0 JRNL AUTH P.MUKHERJEE,H.LI,I.SEVRIOUKOVA,G.CHREIFI,P.MARTASEK, JRNL AUTH 2 L.J.ROMAN,T.L.POULOS,R.B.SILVERMAN JRNL TITL NOVEL 2,4-DISUBSTITUTED PYRIMIDINES AS POTENT, SELECTIVE, JRNL TITL 2 AND CELL-PERMEABLE INHIBITORS OF NEURONAL NITRIC OXIDE JRNL TITL 3 SYNTHASE. JRNL REF J.MED.CHEM. V. 58 1067 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25489882 JRNL DOI 10.1021/JM501719E REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.890 REMARK 3 COMPLETENESS FOR RANGE (%) : 70.6 REMARK 3 NUMBER OF REFLECTIONS : 42502 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2083 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.9778 - 5.0563 1.00 4066 214 0.1419 0.1777 REMARK 3 2 5.0563 - 4.0147 1.00 3860 222 0.1212 0.2003 REMARK 3 3 4.0147 - 3.5075 1.00 3840 205 0.1542 0.2644 REMARK 3 4 3.5075 - 3.1870 1.00 3863 175 0.1973 0.2871 REMARK 3 5 3.1870 - 2.9587 1.00 3796 227 0.2416 0.2794 REMARK 3 6 2.9587 - 2.7843 1.00 3771 203 0.2475 0.3298 REMARK 3 7 2.7843 - 2.6449 1.00 3804 186 0.2644 0.3092 REMARK 3 8 2.6449 - 2.5298 0.99 3753 188 0.2567 0.3243 REMARK 3 9 2.5298 - 2.4324 0.84 3185 153 0.2685 0.3727 REMARK 3 10 2.4324 - 2.3485 0.58 2168 96 0.2772 0.3369 REMARK 3 11 2.3485 - 2.2750 0.40 1501 87 0.2699 0.3097 REMARK 3 12 2.2750 - 2.2100 0.29 1085 68 0.3164 0.3299 REMARK 3 13 2.2100 - 2.1518 0.21 805 28 0.2918 0.4577 REMARK 3 14 2.1518 - 2.0993 0.15 573 18 0.3065 0.6182 REMARK 3 15 2.0993 - 2.0516 0.09 349 13 0.3555 0.4021 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 7058 REMARK 3 ANGLE : 1.220 9609 REMARK 3 CHIRALITY : 0.077 995 REMARK 3 PLANARITY : 0.005 1213 REMARK 3 DIHEDRAL : 15.494 2567 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 299:716) REMARK 3 ORIGIN FOR THE GROUP (A): 11.2863 4.7480 22.5249 REMARK 3 T TENSOR REMARK 3 T11: 0.0857 T22: 0.0732 REMARK 3 T33: 0.0848 T12: -0.0194 REMARK 3 T13: 0.0132 T23: -0.0117 REMARK 3 L TENSOR REMARK 3 L11: 0.3892 L22: 0.7042 REMARK 3 L33: 2.3768 L12: -0.0923 REMARK 3 L13: -0.2663 L23: 0.2040 REMARK 3 S TENSOR REMARK 3 S11: -0.0358 S12: 0.0915 S13: -0.0484 REMARK 3 S21: 0.0281 S22: -0.0602 S23: 0.0445 REMARK 3 S31: 0.1213 S32: -0.2111 S33: -0.0127 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESID 299:718) REMARK 3 ORIGIN FOR THE GROUP (A): 12.3668 4.8912 59.9120 REMARK 3 T TENSOR REMARK 3 T11: -0.0366 T22: 0.0729 REMARK 3 T33: 0.0875 T12: 0.1142 REMARK 3 T13: 0.0326 T23: 0.0086 REMARK 3 L TENSOR REMARK 3 L11: 0.3785 L22: 0.6732 REMARK 3 L33: 1.4227 L12: -0.1738 REMARK 3 L13: 0.0397 L23: 0.1693 REMARK 3 S TENSOR REMARK 3 S11: -0.0080 S12: -0.0067 S13: 0.0489 REMARK 3 S21: -0.1242 S22: -0.0810 S23: -0.0190 REMARK 3 S31: 0.0958 S32: 0.0333 S33: 0.0260 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4V3Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1290062001. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.127 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60071 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-24% PEG3350 0.1M MES 10% ETHYLENE REMARK 280 GLYCOL 140-200 MM AMMONIUM ACETATE 5 MM GSH 35UM SDS, PH 5.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.89500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.06500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.52500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.06500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.89500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.52500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -87.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 297 REMARK 465 PRO A 298 REMARK 465 SER A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 THR A 342 REMARK 465 ARG A 343 REMARK 465 LYS A 344 REMARK 465 PRO A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 VAL A 348 REMARK 465 ARG A 349 REMARK 465 GLY A 718 REMARK 465 CYS B 297 REMARK 465 PRO B 298 REMARK 465 SER B 339 REMARK 465 GLN B 340 REMARK 465 HIS B 341 REMARK 465 THR B 342 REMARK 465 ARG B 343 REMARK 465 LYS B 344 REMARK 465 PRO B 345 REMARK 465 GLU B 346 REMARK 465 ASP B 347 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 717 CA C O CB CG CD CE REMARK 470 LYS A 717 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 392 -23.48 72.47 REMARK 500 THR A 393 -167.18 -120.79 REMARK 500 LYS A 423 58.27 -96.89 REMARK 500 THR A 466 -76.95 -115.32 REMARK 500 ARG A 514 57.33 37.64 REMARK 500 LYS A 550 -29.51 -145.39 REMARK 500 CYS A 582 57.35 -152.95 REMARK 500 ARG A 603 -136.33 -130.83 REMARK 500 ASP A 617 87.27 -66.42 REMARK 500 ARG A 669 -11.37 -141.55 REMARK 500 SER B 392 -24.01 78.91 REMARK 500 THR B 393 -157.74 -131.17 REMARK 500 ALA B 429 31.72 -96.29 REMARK 500 THR B 466 -88.41 -114.52 REMARK 500 CYS B 582 53.27 -153.99 REMARK 500 ARG B 603 -134.83 -121.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1717 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 326 SG REMARK 620 2 CYS A 331 SG 115.6 REMARK 620 3 CYS B 326 SG 121.1 101.9 REMARK 620 4 CYS B 331 SG 98.5 103.4 115.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 415 SG REMARK 620 2 HEM A 750 NA 97.3 REMARK 620 3 HEM A 750 NB 93.2 87.7 REMARK 620 4 HEM A 750 NC 89.1 173.3 89.9 REMARK 620 5 HEM A 750 ND 96.3 87.6 169.9 93.7 REMARK 620 6 9HL A 800 N01 173.3 86.7 81.5 86.7 89.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 415 SG REMARK 620 2 HEM B 750 NA 90.2 REMARK 620 3 HEM B 750 NB 89.7 90.9 REMARK 620 4 HEM B 750 NC 81.9 172.1 88.1 REMARK 620 5 HEM B 750 ND 87.3 87.8 176.7 92.8 REMARK 620 6 9HL B 800 N01 171.4 98.4 89.4 89.5 93.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9HL A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9HL B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1717 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)ETHYL-(S,R)-2- REMARK 900 (3-FLUOROBENZYL) CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D2Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)ETHYL-(R,S)-2- REMARK 900 (3-FLUOROBENZYL) CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D30 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)ETHYL-3- REMARK 900 (PYRIDIN-3-YL)PROPAN-1- AMINE REMARK 900 RELATED ID: 4D31 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)-N-(3- REMARK 900 CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D32 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2-(2-( 5-METHYL-1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYLPROPAN -1-AMINE REMARK 900 RELATED ID: 4D33 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH (N1-(2-(1H-IMIDAZOL-1- YL)PYRIMIDIN-4-YL)-N2-(3- REMARK 900 FLUOROPHENETHYL)ETHANE-1,2 -DIAMINE REMARK 900 RELATED ID: 4D34 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL )PYRIMIDIN-4-YL)-N-(3- REMARK 900 FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D35 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3- REMARK 900 FLUOROPHENYL)PROPAN-1 -AMINE REMARK 900 RELATED ID: 4D36 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3- REMARK 900 CHLOROPHENYL)PROPAN-1 -AMINE REMARK 900 RELATED ID: 4D37 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITHN-{[(1R,2R)-2-(3- FLUOROPHENYL)CYCLOPROPYL]METHYL}-2- REMARK 900 [2-(1H-IMIDAZOL-1- YL)PYRIMIDIN-4-YL]ETHANAMINE REMARK 900 RELATED ID: 4D38 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 -YL)PYRIMIDIN-4-YL)ETHYL-(S,R) REMARK 900 -2-(3-FLUOROBENZYL) CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D39 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)-N-(3- REMARK 900 CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D3A RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN REMARK 900 IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2 -(2-(5-METHYL-1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL) ETHYLPROPAN-1-AMINE REMARK 900 RELATED ID: 4D3B RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N1-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)-N2-(3- REMARK 900 FLUOROPHENETHYL)ETHANE-1,2- DIAMINE REMARK 900 RELATED ID: 4V3U RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN IN COMPLEX REMARK 900 WITH N-2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL) REMARK 900 PROPAN-1- AMINE REMARK 900 RELATED ID: 4V3V RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-(2-(1H-IMIDAZOL-1-YL)-4- PYRIMIDYLMETHYL)-3-(3- REMARK 900 FLUOROPHENYL)PROPAN-1-AMINE REMARK 900 RELATED ID: 4V3W RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)-N-(3- REMARK 900 FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4V3X RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)ETHYL-3-(3- REMARK 900 FLUOROPHENYL)PROPAN-1- AMINE REMARK 900 RELATED ID: 4V3Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN IN REMARK 900 COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) PYRIMIDIN-4-YL)ETHYL-3-(3- REMARK 900 CHLOROPHENYL)PROPAN-1- AMINE DBREF 4V3Z A 297 718 UNP P29476 NOS1_RAT 297 718 DBREF 4V3Z B 297 718 UNP P29476 NOS1_RAT 297 718 SEQRES 1 A 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 A 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 A 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 A 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 A 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 A 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 A 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 A 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 A 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 A 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 A 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 A 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 A 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 A 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 A 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 A 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 A 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 A 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 A 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 A 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 A 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 A 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 A 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 A 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 A 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 A 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 A 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 A 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 A 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 A 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 A 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 A 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 A 422 THR HIS VAL TRP LYS GLY SEQRES 1 B 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 B 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 B 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 B 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 B 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 B 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 B 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 B 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 B 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 B 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 B 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 B 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 B 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 B 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 B 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 B 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 B 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 B 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 B 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 B 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 B 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 B 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 B 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 B 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 B 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 B 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 B 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 B 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 B 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 B 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 B 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 B 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 B 422 THR HIS VAL TRP LYS GLY HET HEM A 750 43 HET H4B A 760 17 HET 9HL A 800 25 HET ACT A 860 4 HET ZN A1717 1 HET HEM B 750 43 HET H4B B 760 17 HET 9HL B 800 25 HET ACT B 860 4 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM 9HL N-{[(1R,2R)-2-(3-FLUOROPHENYL)CYCLOPROPYL]METHYL}-2-[2- HETNAM 2 9HL (1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL]ETHANAMINE HETNAM ACT ACETATE ION HETNAM ZN ZINC ION HETSYN HEM HEME HETSYN 9HL 2-(2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)-N-(2-(3- HETSYN 2 9HL FLUOROPHENYL)CYCLOPROPYLMETHYL)ETHAN-1-AMINE FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 H4B 2(C9 H15 N5 O3) FORMUL 5 9HL 2(C19 H20 F N5) FORMUL 6 ACT 2(C2 H3 O2 1-) FORMUL 7 ZN ZN 2+ FORMUL 12 HOH *254(H2 O) HELIX 1 1 THR A 315 SER A 320 5 6 HELIX 2 2 LYS A 351 ILE A 369 1 19 HELIX 3 3 SER A 374 SER A 392 1 19 HELIX 4 4 LYS A 397 ASN A 411 1 15 HELIX 5 5 GLY A 417 TRP A 421 5 5 HELIX 6 6 THR A 434 ASN A 451 1 18 HELIX 7 7 LYS A 452 ASN A 454 5 3 HELIX 8 8 ASN A 498 GLY A 509 1 12 HELIX 9 9 PRO A 537 VAL A 541 5 5 HELIX 10 10 TRP A 553 GLY A 558 5 6 HELIX 11 11 MET A 589 VAL A 595 1 7 HELIX 12 12 VAL A 595 ASP A 600 1 6 HELIX 13 13 ILE A 606 ASP A 615 1 10 HELIX 14 14 LYS A 620 SER A 623 5 4 HELIX 15 15 LEU A 624 ASP A 644 1 21 HELIX 16 16 ASP A 650 GLY A 670 1 21 HELIX 17 17 ASP A 675 VAL A 680 1 6 HELIX 18 18 SER A 684 GLN A 693 5 10 HELIX 19 19 ASP A 709 THR A 713 5 5 HELIX 20 20 THR B 315 SER B 320 5 6 HELIX 21 21 THR B 350 ILE B 369 1 20 HELIX 22 22 SER B 374 SER B 392 1 19 HELIX 23 23 LYS B 397 ASN B 411 1 15 HELIX 24 24 GLY B 417 TRP B 421 5 5 HELIX 25 25 THR B 434 ASN B 451 1 18 HELIX 26 26 LYS B 452 ASN B 454 5 3 HELIX 27 27 ASN B 498 GLN B 508 1 11 HELIX 28 28 PRO B 537 VAL B 541 5 5 HELIX 29 29 PHE B 554 GLY B 558 5 5 HELIX 30 30 MET B 589 VAL B 595 1 7 HELIX 31 31 VAL B 595 ASP B 600 1 6 HELIX 32 32 ILE B 606 ASP B 615 1 10 HELIX 33 33 LYS B 620 SER B 623 5 4 HELIX 34 34 LEU B 624 ASP B 644 1 21 HELIX 35 35 ASP B 650 GLY B 670 1 21 HELIX 36 36 ASP B 675 VAL B 680 1 6 HELIX 37 37 SER B 684 THR B 688 5 5 HELIX 38 38 ASP B 709 THR B 713 5 5 SHEET 1 A 2 LEU A 301 LYS A 304 0 SHEET 2 A 2 VAL A 311 ASP A 314 -1 O ASP A 314 N LEU A 301 SHEET 1 B 4 GLN A 425 ASP A 428 0 SHEET 2 B 4 ALA A 458 ILE A 461 1 O ILE A 461 N PHE A 427 SHEET 3 B 4 PHE A 584 SER A 585 -1 O SER A 585 N ALA A 458 SHEET 4 B 4 ALA A 566 VAL A 567 -1 N VAL A 567 O PHE A 584 SHEET 1 C 3 ARG A 473 VAL A 474 0 SHEET 2 C 3 LEU A 522 GLN A 525 -1 O GLN A 525 N ARG A 473 SHEET 3 C 3 GLU A 532 PHE A 534 -1 O PHE A 534 N LEU A 522 SHEET 1 D 2 GLY A 484 LYS A 486 0 SHEET 2 D 2 THR A 492 GLY A 494 -1 O LEU A 493 N TYR A 485 SHEET 1 E 2 GLU A 543 PRO A 545 0 SHEET 2 E 2 LYS A 560 TYR A 562 -1 O TRP A 561 N VAL A 544 SHEET 1 F 3 LEU A 577 PHE A 579 0 SHEET 2 F 3 LEU A 571 ILE A 574 -1 N LEU A 572 O PHE A 579 SHEET 3 F 3 SER A 703 GLU A 705 -1 O GLU A 705 N LEU A 571 SHEET 1 G 2 LEU B 301 LYS B 304 0 SHEET 2 G 2 VAL B 311 ASP B 314 -1 O ASP B 314 N LEU B 301 SHEET 1 H 4 GLN B 425 ASP B 428 0 SHEET 2 H 4 ALA B 458 ILE B 461 1 O ILE B 459 N PHE B 427 SHEET 3 H 4 PHE B 584 SER B 585 -1 O SER B 585 N ALA B 458 SHEET 4 H 4 ALA B 566 VAL B 567 -1 N VAL B 567 O PHE B 584 SHEET 1 I 3 ARG B 473 VAL B 474 0 SHEET 2 I 3 LEU B 522 GLN B 525 -1 O GLN B 525 N ARG B 473 SHEET 3 I 3 GLU B 532 PHE B 534 -1 O PHE B 534 N LEU B 522 SHEET 1 J 2 GLY B 484 LYS B 486 0 SHEET 2 J 2 THR B 492 GLY B 494 -1 O LEU B 493 N TYR B 485 SHEET 1 K 2 GLU B 543 PRO B 545 0 SHEET 2 K 2 LYS B 560 TYR B 562 -1 O TRP B 561 N VAL B 544 SHEET 1 L 3 LEU B 577 PHE B 579 0 SHEET 2 L 3 LEU B 571 ILE B 574 -1 N LEU B 572 O PHE B 579 SHEET 3 L 3 SER B 703 GLU B 705 -1 O GLU B 705 N LEU B 571 LINK SG CYS A 326 ZN ZN A1717 1555 1555 2.31 LINK SG CYS A 331 ZN ZN A1717 1555 1555 2.33 LINK SG CYS A 415 FE HEM A 750 1555 1555 2.48 LINK FE HEM A 750 N01 9HL A 800 1555 1555 2.31 LINK ZN ZN A1717 SG CYS B 326 1555 1555 2.44 LINK ZN ZN A1717 SG CYS B 331 1555 1555 2.31 LINK SG CYS B 415 FE HEM B 750 1555 1555 2.48 LINK FE HEM B 750 N01 9HL B 800 1555 1555 2.24 CISPEP 1 THR A 701 PRO A 702 0 -0.73 CISPEP 2 THR B 701 PRO B 702 0 0.54 SITE 1 AC1 18 TRP A 409 ALA A 412 CYS A 415 VAL A 416 SITE 2 AC1 18 SER A 457 MET A 570 PHE A 584 SER A 585 SITE 3 AC1 18 TRP A 587 GLU A 592 TRP A 678 TYR A 706 SITE 4 AC1 18 H4B A 760 9HL A 800 ACT A 860 HOH A2084 SITE 5 AC1 18 HOH A2117 HOH A2118 SITE 1 AC2 15 SER A 334 ARG A 596 VAL A 677 TRP A 678 SITE 2 AC2 15 HEM A 750 HOH A2008 HOH A2084 HOH A2085 SITE 3 AC2 15 HOH A2104 HOH A2106 TRP B 676 PHE B 691 SITE 4 AC2 15 HIS B 692 GLN B 693 GLU B 694 SITE 1 AC3 9 MET A 336 LEU A 337 GLN A 478 PRO A 565 SITE 2 AC3 9 VAL A 567 GLU A 592 TRP A 678 HEM A 750 SITE 3 AC3 9 TRP B 306 SITE 1 AC4 3 TRP A 587 VAL A 649 HEM A 750 SITE 1 AC5 16 TRP B 409 CYS B 415 VAL B 416 PHE B 584 SITE 2 AC5 16 SER B 585 GLY B 586 TRP B 587 GLU B 592 SITE 3 AC5 16 TRP B 678 PHE B 704 TYR B 706 H4B B 760 SITE 4 AC5 16 9HL B 800 HOH B2133 HOH B2134 HOH B2135 SITE 1 AC6 14 TRP A 676 PHE A 691 HIS A 692 GLN A 693 SITE 2 AC6 14 GLU A 694 SER B 334 ARG B 596 VAL B 677 SITE 3 AC6 14 TRP B 678 HEM B 750 HOH B2024 HOH B2112 SITE 4 AC6 14 HOH B2130 HOH B2134 SITE 1 AC7 9 TRP A 306 MET B 336 LEU B 337 GLN B 478 SITE 2 AC7 9 PRO B 565 VAL B 567 TRP B 678 TYR B 706 SITE 3 AC7 9 HEM B 750 SITE 1 AC8 4 GLN B 420 TRP B 587 VAL B 649 HOH B2123 SITE 1 AC9 4 CYS A 326 CYS A 331 CYS B 326 CYS B 331 CRYST1 51.790 111.050 164.130 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019309 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006093 0.00000